메뉴 건너뛰기




Volumn 17, Issue 6, 2008, Pages 1131-1138

Advanced glycation endproduct-induced diabetic complications

Author keywords

Advanced glycation endproduct; Diabetes mellitus; Diabetic complication; Inhibitor; Reactive oxygen species (ros)

Indexed keywords


EID: 61349086178     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (4)

References (74)
  • 1
    • 5144225814 scopus 로고    scopus 로고
    • Management of gestational diabetes mellitus and pharmacists' role in patient education
    • Evans E, Patry R. Management of gestational diabetes mellitus and pharmacists' role in patient education. Am. J. Health-Syst. Ph, 61: 1460-1465 (2004)
    • (2004) Am. J. Health-Syst. Ph , vol.61 , pp. 1460-1465
    • Evans, E.1    Patry, R.2
  • 2
    • 33645657561 scopus 로고    scopus 로고
    • Diabetic peripheral neuropathic pain: Clinical and quality-of-life issues
    • Argoff CE, Cole BE, Fishbain DA, Irving GA. Diabetic peripheral neuropathic pain: Clinical and quality-of-life issues. Mayo Clin. Proc. 81:3-11 (2006)
    • (2006) Mayo Clin. Proc , vol.81 , pp. 3-11
    • Argoff, C.E.1    Cole, B.E.2    Fishbain, D.A.3    Irving, G.A.4
  • 3
    • 33644502854 scopus 로고    scopus 로고
    • The metabolic syndrome: Prevalence, CHD risk, and treatment
    • Sarti C, Gallagher J. The metabolic syndrome: Prevalence, CHD risk, and treatment. J. Diabetes Complicat, 20: 121-132 (2006)
    • (2006) J. Diabetes Complicat , vol.20 , pp. 121-132
    • Sarti, C.1    Gallagher, J.2
  • 4
    • 22444451523 scopus 로고    scopus 로고
    • Five years of research on health risks and benefits of Maillard reaction products: An update
    • Somoza V. Five years of research on health risks and benefits of Maillard reaction products: An update. Mol. Nutr. Food Res. 49: 663-672 (2005)
    • (2005) Mol. Nutr. Food Res , vol.49 , pp. 663-672
    • Somoza, V.1
  • 5
    • 0032029363 scopus 로고    scopus 로고
    • AGEs and their interactions with AGE receptors in vascular disease and diabetes mellitus: AGE concept
    • Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP. AGEs and their interactions with AGE receptors in vascular disease and diabetes mellitus: AGE concept. Cardiovasc. Res. 37: 586-600 (1998)
    • (1998) Cardiovasc. Res , vol.37 , pp. 586-600
    • Bierhaus, A.1    Hofmann, M.A.2    Ziegler, R.3    Nawroth, P.P.4
  • 7
    • 33645832576 scopus 로고    scopus 로고
    • Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy
    • Yamagishi S, Nakamura K, Matsui T. Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy. Curr. Drug. Discov. Technol. 3: 83-88 (2006)
    • (2006) Curr. Drug. Discov. Technol , vol.3 , pp. 83-88
    • Yamagishi, S.1    Nakamura, K.2    Matsui, T.3
  • 8
    • 33645875855 scopus 로고    scopus 로고
    • Intensive diabetes treatment and cardiovascular disease
    • Weissman AJ, Intensive diabetes treatment and cardiovascular disease. New Engl. J. Med. 354:1751-1752 (2006)
    • (2006) New Engl. J. Med , vol.354 , pp. 1751-1752
    • Weissman, A.J.1
  • 9
    • 34447512444 scopus 로고    scopus 로고
    • Inhibitors of aldose reductase and advanced glycation end-products formation from the leaves of Stelechocarpus cauliflorus R.E. Fr
    • Wirasathien L, Pengsuparp T, Suttisri R, Ueda H, Moriyasu M, Kawanishi K. Inhibitors of aldose reductase and advanced glycation end-products formation from the leaves of Stelechocarpus cauliflorus R.E. Fr. Phytomedicine 14: 546-550 (2007)
    • (2007) Phytomedicine , vol.14 , pp. 546-550
    • Wirasathien, L.1    Pengsuparp, T.2    Suttisri, R.3    Ueda, H.4    Moriyasu, M.5    Kawanishi, K.6
  • 10
    • 33748462858 scopus 로고    scopus 로고
    • Jang DS, Kim JM, Lee YM, Kim YS, Kim JH, Kim JS. Puerariafuran, a new inhibitor of advanced glycation end products (AGEs) isolated from the roots of Pueraria lobata. Chem. Pharm. Bull. 54: 1315-1317(2006)
    • Jang DS, Kim JM, Lee YM, Kim YS, Kim JH, Kim JS. Puerariafuran, a new inhibitor of advanced glycation end products (AGEs) isolated from the roots of Pueraria lobata. Chem. Pharm. Bull. 54: 1315-1317(2006)
  • 11
    • 0027275397 scopus 로고
    • The effect of long-term, intensified insulin treatment on the development of microvascular complications of diabetes mellitus
    • Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term, intensified insulin treatment on the development of microvascular complications of diabetes mellitus. New Engl. J. Med. 329: 304-309 (1993)
    • (1993) New Engl. J. Med , vol.329 , pp. 304-309
    • Reichard, P.1    Nilsson, B.Y.2    Rosenqvist, U.3
  • 12
    • 0022402607 scopus 로고
    • Near normoglycaemia improved nerve conduction and vibration in diabetic neuropathy
    • Service FJ
    • Service FJ, Rizza RA, Daube JR, OBrian PC, Dyck PJ. Near normoglycaemia improved nerve conduction and vibration in diabetic neuropathy. Diabetologia 28: 722-727 (1985)
    • (1985) Diabetologia , vol.28 , pp. 722-727
    • Rizza, R.A.1    Daube, J.R.2    OBrian, P.C.3    Dyck, P.J.4
  • 13
    • 0035856980 scopus 로고    scopus 로고
    • Biochemistry and molecular cell biology of diabetic complications
    • Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820 (2001)
    • (2001) Nature , vol.414 , pp. 813-820
    • Brownlee, M.1
  • 15
    • 28844462418 scopus 로고    scopus 로고
    • Pacher P, Szabo C. Role of poly (ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: Endothelial dysfunction, as a common underlying theme. Antioxid, Redox. Sign. 7: 1568-1580(2004)
    • Pacher P, Szabo C. Role of poly (ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: Endothelial dysfunction, as a common underlying theme. Antioxid, Redox. Sign. 7: 1568-1580(2004)
  • 17
    • 1842855377 scopus 로고    scopus 로고
    • Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency
    • Ii S, Ohta M, Kudo E, Yamaoka T, Tachikawa T. Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency. Diabetologia 47: 541-544 (2004)
    • (2004) Diabetologia , vol.47 , pp. 541-544
    • Ii, S.1    Ohta, M.2    Kudo, E.3    Yamaoka, T.4    Tachikawa, T.5
  • 18
    • 0025172693 scopus 로고
    • Protein kinase C-mediated contractile responses of arteries from diabetic rats
    • Abebe W, MacLeod KM. Protein kinase C-mediated contractile responses of arteries from diabetic rats. Brit. J. Pharmacol. 101: 465-471 (1990)
    • (1990) Brit. J. Pharmacol , vol.101 , pp. 465-471
    • Abebe, W.1    MacLeod, K.M.2
  • 19
    • 0024340324 scopus 로고
    • Effects of streptozotocin-induced hyperglycemia on agonist-stimulated phosphoinositol turnover in rat aorta
    • Legan E. Effects of streptozotocin-induced hyperglycemia on agonist-stimulated phosphoinositol turnover in rat aorta. Life Sci. 45: 371-378 (1989)
    • (1989) Life Sci , vol.45 , pp. 371-378
    • Legan, E.1
  • 20
    • 33748909141 scopus 로고    scopus 로고
    • Palm F. Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy. Clin, Exp, Pharmacol. P. 33: 997-1001 (2006)
    • Palm F. Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy. Clin, Exp, Pharmacol. P. 33: 997-1001 (2006)
  • 21
    • 0031975643 scopus 로고    scopus 로고
    • High glucose-induced transforming growth factor betal production is mediated by the hexosamine pathway in porcine glomerular mesangial cells
    • Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED. High glucose-induced transforming growth factor betal production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J. Clin. Invest 101: 160-169 (1998)
    • (1998) J. Clin. Invest , vol.101 , pp. 160-169
    • Kolm-Litty, V.1    Sauer, U.2    Nerlich, A.3    Lehmann, R.4    Schleicher, E.D.5
  • 22
    • 20444479826 scopus 로고    scopus 로고
    • Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications
    • Xu Y, He Z, King GL. Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications. Curr. Diab. Rep. 5: 91-97 (2005)
    • (2005) Curr. Diab. Rep , vol.5 , pp. 91-97
    • Xu, Y.1    He, Z.2    King, G.L.3
  • 24
    • 0141997270 scopus 로고    scopus 로고
    • Advanced glycation end-products pentosidine and N-carboxymethyllysine are elevated in serum of patients with osteoporosis
    • Hein G, Wiegand R, Lehmann G, Stein Q Franke S. Advanced glycation end-products pentosidine and N-carboxymethyllysine are elevated in serum of patients with osteoporosis. Rheumatology 42: 1242-1246 (2003)
    • (2003) Rheumatology , vol.42 , pp. 1242-1246
    • Hein, G.1    Wiegand, R.2    Lehmann, G.3    Stein, Q.4    Franke, S.5
  • 25
    • 0033055417 scopus 로고    scopus 로고
    • Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesion
    • Suzuki D, Miyata T, Saotome N, Horie K, Inagi R. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesion. J. Am. Soc. Nephrol. 10: 822-832 (1999)
    • (1999) J. Am. Soc. Nephrol , vol.10 , pp. 822-832
    • Suzuki, D.1    Miyata, T.2    Saotome, N.3    Horie, K.4    Inagi, R.5
  • 26
    • 0034648768 scopus 로고    scopus 로고
    • Atherosclerosis
    • Lusis AJ. Atherosclerosis. Nature 407: 233-241 (2000)
    • (2000) Nature , vol.407 , pp. 233-241
    • Lusis, A.J.1
  • 27
    • 0028979597 scopus 로고
    • Ne(carboxymethyl) lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins
    • Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW. Ne(carboxymethyl) lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34: 10872-10878 (1995)
    • (1995) Biochemistry , vol.34 , pp. 10872-10878
    • Reddy, S.1    Bichler, J.2    Wells-Knecht, K.J.3    Thorpe, S.R.4    Baynes, J.W.5
  • 30
    • 0032810308 scopus 로고    scopus 로고
    • Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients
    • Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients. Mol. Med. 5: 393-405 (1999)
    • (1999) Mol. Med , vol.5 , pp. 393-405
  • 31
    • 33748354683 scopus 로고    scopus 로고
    • Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiols
    • Zeng J, Dunlop RA, Rodgers KJ, Davies MJ. Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiols. Biochem. J. 398: 197-206 (2006)
    • (2006) Biochem. J , vol.398 , pp. 197-206
    • Zeng, J.1    Dunlop, R.A.2    Rodgers, K.J.3    Davies, M.J.4
  • 33
    • 0030907178 scopus 로고    scopus 로고
    • Vascular hypertrophy in experimental diabetes: Role of advanced glycation end-products
    • Rumble JR, Cooper ME, Soulis-Liparota T, Cox A, Wu L. Vascular hypertrophy in experimental diabetes: Role of advanced glycation end-products, J, Clin. Invest. 99: 1016-1027 (1997)
    • (1997) J, Clin. Invest , vol.99 , pp. 1016-1027
    • Rumble, J.R.1    Cooper, M.E.2    Soulis-Liparota, T.3    Cox, A.4    Wu, L.5
  • 34
    • 0028559801 scopus 로고
    • Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats: Effect of aminoguanidine treatment
    • Hill MA, Ege EA. Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats: Effect of aminoguanidine treatment. Diabetes 43: 1450-1456 (1994)
    • (1994) Diabetes , vol.43 , pp. 1450-1456
    • Hill, M.A.1    Ege, E.A.2
  • 35
    • 33746920337 scopus 로고    scopus 로고
    • Advanced glycation end products sparking the development of diabetic vascular injury
    • Goldin A, Joshua AB, Schmidt AM, Creager MA. Advanced glycation end products sparking the development of diabetic vascular injury. Circulation 114: 597-605 (2006)
    • (2006) Circulation , vol.114 , pp. 597-605
    • Goldin, A.1    Joshua, A.B.2    Schmidt, A.M.3    Creager, M.A.4
  • 36
    • 18144432360 scopus 로고    scopus 로고
    • Scanning force microscopy reveals structural alterations in diabetic rat collagen fibrils: Role of protein glycation
    • Odetti P, Aragno I, Rolandi R, Garibaldi S, Valentini S. Scanning force microscopy reveals structural alterations in diabetic rat collagen fibrils: Role of protein glycation, Diabetes Metab. 16: 74- 81 (2000)
    • (2000) Diabetes Metab , vol.16 , pp. 74-81
    • Odetti, P.1    Aragno, I.2    Rolandi, R.3    Garibaldi, S.4    Valentini, S.5
  • 37
    • 0028304625 scopus 로고
    • Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/binding proteins
    • Yan SD, Schmidt AM, Anderson MQ Zhang J, Brett J. Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/binding proteins. J. Biol, Chem. 269: 9889-9897 (1994)
    • (1994) J. Biol, Chem , vol.269 , pp. 9889-9897
    • Yan, S.D.1    Schmidt, A.M.2    Anderson, M.Q.3    Zhang, J.4    Brett, J.5
  • 39
    • 0028068046 scopus 로고
    • Cellular receptors for advanced glycation end-products: Implication for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions
    • Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stem D. Cellular receptors for advanced glycation end-products: Implication for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler. Thromb. 14: 1521-1527 (1994)
    • (1994) Arterioscler. Thromb , vol.14 , pp. 1521-1527
    • Schmidt, A.M.1    Hori, O.2    Brett, J.3    Yan, S.D.4    Wautier, J.L.5    Stem, D.6
  • 40
    • 0032076715 scopus 로고    scopus 로고
    • Glyco-oxidized LDL impair endothelial function more potently than oxidized LDL: Role of enhanced oxidative stress
    • Galle J, Schneider R, Winner B, Lehmann-Boden C, Schinzel R. Glyco-oxidized LDL impair endothelial function more potently than oxidized LDL: Role of enhanced oxidative stress. Atherosclerosis 138: 65-77 (1998)
    • (1998) Atherosclerosis , vol.138 , pp. 65-77
    • Galle, J.1    Schneider, R.2    Winner, B.3    Lehmann-Boden, C.4    Schinzel, R.5
  • 41
    • 38349138516 scopus 로고    scopus 로고
    • Donato R. RAGE: A single receptor for several ligands and different cellular responses: The case of certain S100 proteins. Curr. Mol. Med. 7: 711-724 (2007)
    • Donato R. RAGE: A single receptor for several ligands and different cellular responses: The case of certain S100 proteins. Curr. Mol. Med. 7: 711-724 (2007)
  • 42
    • 0034004073 scopus 로고    scopus 로고
    • CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelinmediated stimulation of 0(2)(-) formation
    • Galle J, Lenhmann-Bodem C, Hubner U, Heinloth A, Wanner C. CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelinmediated stimulation of 0(2)(-) formation, Nephrol. Dial. Transpl. 15: 339-346 (2000)
    • (2000) Nephrol. Dial. Transpl , vol.15 , pp. 339-346
    • Galle, J.1    Lenhmann-Bodem, C.2    Hubner, U.3    Heinloth, A.4    Wanner, C.5
  • 43
    • 34547447707 scopus 로고    scopus 로고
    • Oxidative stress, AGE, and atherosclerosis
    • Schleicher E, Friess U. Oxidative stress, AGE, and atherosclerosis. Kidney Int. Suppl. 106: 17-26 (2007)
    • (2007) Kidney Int. Suppl , vol.106 , pp. 17-26
    • Schleicher, E.1    Friess, U.2
  • 44
    • 0030779576 scopus 로고    scopus 로고
    • Plasma and vascular tissue arginine are decreased in diabetes: Acute arginine supplementation restores endotheliumdependent relaxation by augmenting cGMP
    • Pieper GM, Dondlinger LA. Plasma and vascular tissue arginine are decreased in diabetes: Acute arginine supplementation restores endotheliumdependent relaxation by augmenting cGMP. J. Pharmacol. Exp. Ther. 283: 684-691 (1997)
    • (1997) J. Pharmacol. Exp. Ther , vol.283 , pp. 684-691
    • Pieper, G.M.1    Dondlinger, L.A.2
  • 46
    • 48249085391 scopus 로고    scopus 로고
    • Oxidative stress as a major culprit in kidney disease in diabetes
    • Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446-1454 (2008)
    • (2008) Diabetes , vol.57 , pp. 1446-1454
    • Forbes, J.M.1    Coughlan, M.T.2    Cooper, M.E.3
  • 47
    • 0029831898 scopus 로고    scopus 로고
    • Time course study of oxidative stress in aorta and heart of diabetic rats
    • Kakkar R, Martha SV, Kalra J, Prasad K. Time course study of oxidative stress in aorta and heart of diabetic rats. Clin. Sci. 91:441-448 (1996)
    • (1996) Clin. Sci , vol.91 , pp. 441-448
    • Kakkar, R.1    Martha, S.V.2    Kalra, J.3    Prasad, K.4
  • 49
    • 28544448737 scopus 로고    scopus 로고
    • Reactive oxygen, species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney
    • Ha H, Lee HB. Reactive oxygen, species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology 10: 7-10 (2005)
    • (2005) Nephrology , vol.10 , pp. 7-10
    • Ha, H.1    Lee, H.B.2
  • 50
    • 0030737530 scopus 로고    scopus 로고
    • The physiology and pathophysiology of the nitric oxide/superoxide anions
    • Munzel T, Heitzer T, Harrison DG. The physiology and pathophysiology of the nitric oxide/superoxide anions. Herz 22: 158-172 (1997)
    • (1997) Herz , vol.22 , pp. 158-172
    • Munzel, T.1    Heitzer, T.2    Harrison, D.G.3
  • 51
    • 0034107785 scopus 로고    scopus 로고
    • Kinetics and mechanism, of the reaction of aminoguanidine with alphaoxaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions
    • Thornalley PJ, Yurek-George A, Argirov AK. Kinetics and mechanism, of the reaction of aminoguanidine with alphaoxaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions. Biochem. Pharmacol. 60: 55-65 (2000)
    • (2000) Biochem. Pharmacol , vol.60 , pp. 55-65
    • Thornalley, P.J.1    Yurek-George, A.2    Argirov, A.K.3
  • 52
    • 0035966113 scopus 로고    scopus 로고
    • Chelating activity of advanced glycation end-product inhibitors
    • Price DL, Rhett PM, Thorpe SR, Baynes JW, Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem. 276: 48967-48972 (2001)
    • (2001) J. Biol. Chem , vol.276 , pp. 48967-48972
    • Price, D.L.1    Rhett, P.M.2    Thorpe, S.R.3    Baynes, J.W.4
  • 53
    • 33749128745 scopus 로고    scopus 로고
    • Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes
    • Peyroux J, Sternberg M. Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes. Pathol. Biol. 54: 405-419 (2006)
    • (2006) Pathol. Biol , vol.54 , pp. 405-419
    • Peyroux, J.1    Sternberg, M.2
  • 54
    • 0034880114 scopus 로고    scopus 로고
    • Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice
    • Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am, J. Pathol. 159: 513-525 (2001)
    • (2001) Am, J. Pathol , vol.159 , pp. 513-525
    • Goova, M.T.1    Li, J.2    Kislinger, T.3    Qu, W.4    Lu, Y.5    Bucciarelli, L.G.6
  • 56
    • 33645219720 scopus 로고    scopus 로고
    • Renal effects of a neutralizing RAGE-antibody in long-term, streptozotocin-diabetic mice
    • Jensen IJ, Denner I, Schrijers BF, Tilton RG, Rash R, Flyvgerg A. Renal effects of a neutralizing RAGE-antibody in long-term, streptozotocin-diabetic mice. J. Endocrinol. 188: 493-501 (2006)
    • (2006) J. Endocrinol , vol.188 , pp. 493-501
    • Jensen, I.J.1    Denner, I.2    Schrijers, B.F.3    Tilton, R.G.4    Rash, R.5    Flyvgerg, A.6
  • 57
    • 0031054249 scopus 로고    scopus 로고
    • In vitro kinetics studies of formation of antigenic advanced glycation end products (AGEs)
    • Booth AA, Khalifah RQ Todd P, Hudson BG. In vitro kinetics studies of formation of antigenic advanced glycation end products (AGEs). J. Biol. Chem. 272: 5387-5430 (1997)
    • (1997) J. Biol. Chem , vol.272 , pp. 5387-5430
    • Booth, A.A.1    Khalifah, R.Q.2    Todd, P.3    Hudson, B.G.4
  • 58
    • 10744223527 scopus 로고    scopus 로고
    • Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy
    • for the ACTIONI Investigator Group
    • Bolton WK, Cattran DC, Williams ME, Adler SG, Appel GB for the ACTIONI Investigator Group. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am. J. Nephrol. 24: 32-40 (2004)
    • (2004) Am. J. Nephrol , vol.24 , pp. 32-40
    • Bolton, W.K.1    Cattran, D.C.2    Williams, M.E.3    Adler, S.G.4    Appel, G.B.5
  • 59
    • 10644246127 scopus 로고    scopus 로고
    • Advanced glycation end-product cross-link breakers: A novel approach to cardiovascular pathologies related to the aging process
    • Bakris GL, Bank AJ, Kass DA, Neutel JM, Preston RA, Oparil S. Advanced glycation end-product cross-link breakers: A novel approach to cardiovascular pathologies related to the aging process. Am. J. Hypertens. 17: 23-30 (2004)
    • (2004) Am. J. Hypertens , vol.17 , pp. 23-30
    • Bakris, G.L.1    Bank, A.J.2    Kass, D.A.3    Neutel, J.M.4    Preston, R.A.5    Oparil, S.6
  • 60
    • 0034647739 scopus 로고    scopus 로고
    • Pyrodoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions
    • Onorato JM, Jenkins AJ, Thorpe SR, Baynes JW. Pyrodoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. J. Biol. Chem. 275: 21177-21184 (2000)
    • (2000) J. Biol. Chem , vol.275 , pp. 21177-21184
    • Onorato, J.M.1    Jenkins, A.J.2    Thorpe, S.R.3    Baynes, J.W.4
  • 62
    • 23744514571 scopus 로고    scopus 로고
    • Pyridoxamine: The many virtues of a maillard reaction inhibitor
    • Voziyan PA, Hudson BG, Pyridoxamine: The many virtues of a maillard reaction inhibitor. Ann. NY Acad. Sci. 1043: 807-816 (2005)
    • (2005) Ann. NY Acad. Sci , vol.1043 , pp. 807-816
    • Voziyan, P.A.1    Hudson, B.G.2
  • 63
    • 0037376556 scopus 로고    scopus 로고
    • AGE-breakers cleave model, compounds but not break Maillard crosslinks in skin and tail collagen from diabetic rats
    • Yang S, Litchfield JE, Baynes JW, AGE-breakers cleave model, compounds but not break Maillard crosslinks in skin and tail collagen from diabetic rats. Arch, Biochem. Biophys. 412: 42-46 (2003)
    • (2003) Arch, Biochem. Biophys , vol.412 , pp. 42-46
    • Yang, S.1    Litchfield, J.E.2    Baynes, J.W.3
  • 64
    • 0142121508 scopus 로고    scopus 로고
    • Therapeutic potential odd breakers of advanced glycation end product-protein cross links
    • Vasan S, Foiles P, Founds H. Therapeutic potential odd breakers of advanced glycation end product-protein cross links, Arch, Biochem. Biophys. 419: 89-96 (2003)
    • (2003) Arch, Biochem. Biophys , vol.419 , pp. 89-96
    • Vasan, S.1    Foiles, P.2    Founds, H.3
  • 65
    • 16244371321 scopus 로고    scopus 로고
    • The effect of alagebrium chloride (ALT 711), a novel glucose crosslink breaker, in treatment of elderly patients with diastolic heart failure
    • Little WC, Zile MR, Kitzman DW, Hundley WG, O'Brien TX, Degroof RC. The effect of alagebrium chloride (ALT 711), a novel glucose crosslink breaker, in treatment of elderly patients with diastolic heart failure. J. Card. Fail. 11: 191-195 (2005)
    • (2005) J. Card. Fail , vol.11 , pp. 191-195
    • Little, W.C.1    Zile, M.R.2    Kitzman, D.W.3    Hundley, W.G.4    O'Brien, T.X.5    Degroof, R.C.6
  • 66
    • 50249151322 scopus 로고    scopus 로고
    • Determining conditions for nitric oxide synthesis in Caco-2 cells using Taguchi and factorial experimental designs
    • Chen XM, Kitts DD. Determining conditions for nitric oxide synthesis in Caco-2 cells using Taguchi and factorial experimental designs. Anal. Biochem. 381: 185-192 (2008)
    • (2008) Anal. Biochem , vol.381 , pp. 185-192
    • Chen, X.M.1    Kitts, D.D.2
  • 67
    • 0142074864 scopus 로고    scopus 로고
    • Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
    • Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem, Biophys. 419: 31-40 (2003)
    • (2003) Arch. Biochem, Biophys , vol.419 , pp. 31-40
    • Thornalley, P.J.1
  • 68
    • 0031785582 scopus 로고    scopus 로고
    • Accumulation of carbonyls accelerates the formation of pentosidine, advanced glycation end product: Carbonyl stress in uremia
    • Miyata T, Ueda Y, Yamada Y, Izuhara Y, Wada T, Jadoui M. Accumulation of carbonyls accelerates the formation of pentosidine, advanced glycation end product: Carbonyl stress in uremia. J. Am. Soc. Nephrol. 9: 2349-2356 (1998)
    • (1998) J. Am. Soc. Nephrol , vol.9 , pp. 2349-2356
    • Miyata, T.1    Ueda, Y.2    Yamada, Y.3    Izuhara, Y.4    Wada, T.5    Jadoui, M.6
  • 69
    • 23744456423 scopus 로고    scopus 로고
    • From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy
    • Miyata T, Yamamoto M, Izuhara Y. From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy. Ann. NY Acad. Sci. 1043: 740-749 (2005)
    • (2005) Ann. NY Acad. Sci , vol.1043 , pp. 740-749
    • Miyata, T.1    Yamamoto, M.2    Izuhara, Y.3
  • 70
    • 23744454175 scopus 로고    scopus 로고
    • Figarola JL, Scott S, Loera S, Xi B, Synold T, Weiss I. Prevention of early renal disease, dyslipidemia, and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74 novel AGE inhibitors. Diabetes Metab. Res. 21: 533-544 (2005)
    • Figarola JL, Scott S, Loera S, Xi B, Synold T, Weiss I. Prevention of early renal disease, dyslipidemia, and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74 novel AGE inhibitors. Diabetes Metab. Res. 21: 533-544 (2005)
  • 71
    • 0036479252 scopus 로고    scopus 로고
    • A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation
    • Voziyan PA, Metz TO, Baynes JW, HudsonBG. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J. Biol. Chem. 277: 3397-3403 (2002)
    • (2002) J. Biol. Chem , vol.277 , pp. 3397-3403
    • Voziyan, P.A.1    Metz, T.O.2    Baynes, J.W.3    HudsonBG4
  • 72
    • 0042266256 scopus 로고    scopus 로고
    • Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine
    • Babei-jadidi R, Karachalian N, Ahmed N, Battab S, Thomalley PJ. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52: 2110-2120 (2003)
    • (2003) Diabetes , vol.52 , pp. 2110-2120
    • Babei-jadidi, R.1    Karachalian, N.2    Ahmed, N.3    Battab, S.4    Thomalley, P.J.5
  • 73
    • 0344837347 scopus 로고    scopus 로고
    • Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy
    • Hammes HP, Du X, Edelstein D, Taguchi T, Matsumara T, Ju Q, Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat. Med. 9: 294-299 (2003)
    • (2003) Nat. Med , vol.9 , pp. 294-299
    • Hammes, H.P.1    Du, X.2    Edelstein, D.3    Taguchi, T.4    Matsumara, T.5    Ju, Q.6
  • 74
    • 15844425230 scopus 로고    scopus 로고
    • An agent cleaving glucose-derived protein crosslinks in vitro and in vivo
    • Vasan S, Zhang X, Karpurniotu A, Bernhagen J, Teichberg S. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382: 211-212 (1996)
    • (1996) Nature , vol.382 , pp. 211-212
    • Vasan, S.1    Zhang, X.2    Karpurniotu, A.3    Bernhagen, J.4    Teichberg, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.